XLXiaodong Liu

Xiaodong Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaodong Liu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Chen

    Department of Endocrinology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China

    2 shared publications
  • Minghui Qin

    Department of Traditional Chinese Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Art and Science Xiangyang China

    2 shared publications
  • Jiawei Hao

    Department of Ultrasound Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441021, Hubei, China

    1 shared publication
  • Meng Zuo

    Department of Ultrasound Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441021, Hubei, China

    1 shared publication
  • Shaohua Sun

    Department of Oncology, Suizhou Central Hospital, Hubei University of Medicine Suizhou China

    1 shared publication
  • Xingyue Wang

    Department of Ultrasound Medicine, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441021, Hubei, China

    1 shared publication

Latest Publications

  • Ultrasound radiomics for identifying microstructural changes in the femoral head with developmental dysplasia of the hip

    by Jiawei Hao, Xingyue Wang, Zheng Pan, Meng Zuo, Yongmei Jia, Yang Lv, Yu Wang, Xiaodong Liu

    Non-invasive imaging methods for evaluating microstructural changes in patients with developmental dysplasia of the hip (DDH) are lacking. To explore the feasibility of hip ultrasound radiomics to evaluate microstructural changes of the femoral head in patients with DDH. A retrospective analysis was conducted on 59 patients with DDH and 66 healthy controls who underwent hip ultrasound examination. We used three-dimensional (3D) Slicer software to obtain femoral head ultrasound radiomics features and compared them between the DDH and healthy control groups. A predictive model was established by using the maximum relevance minimum redundancy (mRMR) and least absolute shrinkage and selection operator (LASSO) methods. The receiver operating characteristic (ROC) curve was used to determine the performance of the model. There were significant differences (P < 0.05) in 69 ultrasound radiomics features of the femoral head between the patients with DDH and healthy controls. By using mRMR, 12 features were selected for further analysis via LASSO. We have successfully established a predictive model based on nine features. The area under the curve (AUC) of the model was 0.91 for the validation set. We developed a predictive model based on ultrasound radiomics, and the model had good differential diagnostic efficacy in patients with DDH and healthy individuals.


  • Open Access

    Effect of Mobile Phone App–Based Interventions on Quality of Life and Psychological Symptoms Among Adult Cancer Survivors: Systematic Review and Meta-analysis of Randomized Controlled Trials

    by Minghui Qin, Bo Chen, Shaohua Sun, Xiaodong Liu

    Background: Most patients with cancer experience psychological or physical distress, which can adversely affect their quality of life (QOL). Smartphone app interventions are increasingly being used to improve QOL and psychological outcomes in patients with cancer. However, there is insufficient evidence regarding the effect of this type of intervention, with conflicting results in the literature. Objective: In this systematic review and meta-analysis, we investigated the effectiveness of mobile phone app interventions on QOL and psychological outcomes in adult patients with cancer, with a special focus on intervention duration, type of cancer, intervention theory, treatment strategy, and intervention delivery format. Methods: We conducted a literature search of PubMed, Web of Science, the Cochrane Library, Embase, Scopus, China National Knowledge Infrastructure, and WanFang to identify studies involving apps that focused on cancer survivors and QOL or psychological symptoms published from inception to October 30, 2022. We selected only randomized controlled trials that met the inclusion criteria and performed systematic review and meta-analysis. The standardized mean difference (SMD) with a 95% CI was pooled when needed. Sensitivity and subgroup analyses were also conducted. Results: In total, 30 randomized controlled trials with a total of 5353 participants were included in this meta-analysis. Compared with routine care, app interventions might improve QOL (SMD=0.39, 95% CI 0.27-0.51; P<.001); enhance self-efficacy (SMD=0.15, 95% CI 0.02-0.29; P=.03); and alleviate anxiety (SMD=−0.64, 95% CI −0.73 to −0.56; P<.001), depression (SMD=−0.33, 95% CI −0.58 to −0.08; P=.009), and distress (SMD=−0.34, 95% CI −0.61 to −0.08; P=.01). Short-term (duration of ≤3 months), physician-patient interaction (2-way communication using a smartphone app), and cognitive behavioral therapy interventions might be the most effective for improving QOL and alleviating adverse psychological effects. Conclusions: Our study showed that interventions using mobile health apps might improve QOL and self-efficacy as well as alleviate anxiety, depression, and distress in adult cancer survivors. However, these results should be interpreted with caution because of the heterogeneity of the interventions and the study design. More rigorous trials are warranted to confirm the suitable duration and validate the different intervention theories as well as address methodological flaws in previous studies. Trial Registration: PROSPERO CRD42022370599; https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=370599


  • Open Access

    Mobile Phone Apps for symptom management in Cancer Survivors: A Systematic Review and Meta-analysis of Randomized Controlled Trials (Preprint)

    by Minghui Qin, Bo Chen, Xiaodong Liu

    BACKGROUND Most cancer patients have psychological or physical distress. This distress can harm their quality of life (QOL). Smartphone application (app) interventions are increasingly being used to improve QOL and psychological outcomes in cancer patients. However, there are still conflicting results in the literature about its effect. OBJECTIVE This review and meta-analysis investigated the effectiveness of mobile phone app interventions on QOL and psychological outcomes in cancer patients, with a special focus on the format of intervention delivery. METHODS We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) from PubMed, The Cochrane Library, Embase, CENTRAL, and China National Knowledge Infrastructure (CNKI), to identify studies involving apps focused on cancer survivors and QoL and/or psychological or physical symptom published from inception to 13 January 2022. Only trial studies which met the inclusion criteria were selected. Standardized mean difference (SMD) with a corresponding 95% confidence interval (95% CI) was pooled when needed. Sensitivity analysis and subgroup analysis were also conducted. RESULTS Twenty five RCTs with a total of 3456 participants were included into this meta-analysis. Compared with routine care, app intervention was associated with higher QOL (SMD = 0.45; 95%CI: 0.28, 0.61; p < 0.05), with less anxiety (SMD = -1.04; 95%CI: -1.67, -0.41; P < 0.001), depression (SMD = -0.36; 95%CI: -0.62, -0.11; P < 0.01), distress (SMD = -0.41; 95%CI: -0.72, -0.10; p < 0.01), fatigue (SMD = -0.42; 95% CI: -0.64, -0.20, p < 0.01), and pain (SMD = -0.33; 95% CI: -0.47, -0.19, p < 0.01). However, anxiety and depression score did not differ significantly between the two groups in breast cancer survivors and in didactic format studies. CONCLUSIONS Our study shows that mobile apps intervention can improve QOL and alleviate anxiety, depression, distress, fatigue, and pain in cancer patients. However, these results should be recognized cautiously due to between-study heterogeneity, indicating that more methodological and well-designed applied research is needed to understand how to better utilize this digital technology to help cancer patients. CLINICALTRIAL This review did not require informed consent or ethical approval because the data derived from previously published studies.